BMS’s Opdivo On Track For Esophageal Cancer Indication

Esophageal cancer
Opdivo Extended Overall Survival In ATTRACTION-3 Trial Versus Chemo • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Immuno-oncology

More from Anticancer